Facility
CollPlant -- Rehovot, Israel
4 Oppenheimer St, Weizmann Science Park, Rehovot. Grows transgenic tobacco plants (COL1A1, COL1A2, hydroxylase genes) to produce recombinant human Type I collagen. Pre-commercial scale as of 2024; primary commercial product is Vergenix STR wound dressing. NASDAQ: CLGN.
0
Inputs produced
0
Goods downstream
0
Incidents on record
0
Stories